Scrophularia

Scrophularia nodosa contains bioactive compounds including harpagoside, aucubin, cinnamic acid derivatives, saponins, and flavonoids. These constituents are believed to support lymphatic circulation and exert mild anti-inflammatory effects on skin and glandular tissues. Harpagoside may modulate inflammatory pathways, while saponins contribute to the herb's traditional cleansing and alterative properties. The herb also demonstrates cardiac-stimulating effects. Evidence level C indicates limited clinical data, with current understanding derived primarily from traditional use and preliminary pharmacological research rather than controlled human trials.

Yes, Scrophularia nodosa should not be combined with cardiac glycoside medications such as digoxin. The herb possesses cardiac-stimulating properties that may potentiate the effects of these drugs, potentially increasing the risk of arrhythmias, toxicity, or other adverse cardiac events. Individuals with existing tachycardia or heart rhythm disorders should also avoid this herb. Always consult a qualified healthcare provider before combining herbal remedies with prescription cardiac medications, as interactions can be serious and dose-dependent.

The traditional adult dosage for Scrophularia nodosa is 2-4 grams of dried herb prepared as a tea, taken three times daily. Alternatively, 1-3ml of tincture may be used three times per day. These recommendations are based on traditional use rather than clinical trials (Evidence level C). Higher doses may cause purgative effects. Always start with lower doses to assess tolerance, and consult a qualified medical herbalist or healthcare provider for individualized guidance, particularly if you have underlying health conditions.

No, Scrophularia nodosa is considered unsafe during pregnancy and should be avoided entirely. The herb contains compounds with cardiac-stimulating properties and may cause uterine contractions or adversely affect fetal development. Traditional use indicates purgative effects at higher doses, which could lead to dehydration and electrolyte imbalances dangerous during pregnancy. Safety data for breastfeeding is insufficient, so avoidance is recommended. Pregnant or nursing individuals should consult a qualified healthcare provider before using any herbal preparations.

Scrophularia nodosa has been used traditionally for lymphatic congestion, swollen glands, and various chronic skin conditions including eczema, psoriasis, and skin eruptions. Historically known as figwort, it was employed in medieval European medicine for glandular swellings and scrofula. Modern herbalists primarily use it as a lymphatic alterative to support detoxification pathways and promote skin health. Evidence level C indicates limited clinical research exists, with current use based primarily on traditional practice and historical applications rather than controlled trials.